Each cell type of the myeloid innate immune system (neutrophils, macrophages, eosinophils, mast cells and basophils) makes a unique contribution to immunity to bacteria and parasites 1 . All of these cell types are generated from multi-potent hematopoietic stem cells (HSCs) in a process controlled by a complex network of transcription factors 2 and extrinsic signals 3 . Knowledge of the cellular pathways by which hematopoietic cell types are generated and how their production is regulated by infectious organisms and cytokines is critical to understanding how the immune system functions and how its dysfunction results in deficiency in or overproduction of immune cells under pathological conditions 4, 5 . Notably, current models for hematopoiesis commonly indicate that all myeloid cell types develop from the same granulocyte-macrophage progenitor populations (pre-granulocytemacrophage progenitor (pre-GM) and granulocyte-macrophage progenitor (GMP); defined as Lin − Sca-1 − c-Kit + CD41 − FcγRII/III + )) 2,6-9 , which according to the CMP-LMPP hematopoietic model are produced by both the CMP branch (which is able to generate myeloid cells, megakaryocytes and erythroid cells but lacks lymphoid-lineage potential 10,11 ) and LMPP branch (which can generate myeloid and lymphoid cell types but lacks megakaryocyte-erythroid (Mk-E)-lineage potential 12 ). Published studies have shown that GMPs have combined monocyte-macrophage and neutrophil potential at the clonal level 6,10 . However, granulocytes also include functionally distinct mast cells, basophils and eosinophils, each specified through the action of critical transcription factors 13 , and the presence of such potential in GMPs has so far not been analyzed systematically. Therefore, whether the LMPP and CMP pathways generate the same complement of myeloid cell types has remained an open question.
Each cell type of the myeloid innate immune system (neutrophils, macrophages, eosinophils, mast cells and basophils) makes a unique contribution to immunity to bacteria and parasites 1 . All of these cell types are generated from multi-potent hematopoietic stem cells (HSCs) in a process controlled by a complex network of transcription factors 2 and extrinsic signals 3 . Knowledge of the cellular pathways by which hematopoietic cell types are generated and how their production is regulated by infectious organisms and cytokines is critical to understanding how the immune system functions and how its dysfunction results in deficiency in or overproduction of immune cells under pathological conditions 4, 5 . Notably, current models for hematopoiesis commonly indicate that all myeloid cell types develop from the same granulocyte-macrophage progenitor populations (pre-granulocytemacrophage progenitor (pre-GM) and granulocyte-macrophage progenitor (GMP); defined as Lin − Sca-1 − c-Kit + CD41 − FcγRII/III + )) 2, [6] [7] [8] [9] , which according to the CMP-LMPP hematopoietic model are produced by both the CMP branch (which is able to generate myeloid cells, megakaryocytes and erythroid cells but lacks lymphoid-lineage potential 10, 11 ) and LMPP branch (which can generate myeloid and lymphoid cell types but lacks megakaryocyte-erythroid (Mk-E)-lineage potential 12 ). Published studies have shown that GMPs have combined monocyte-macrophage and neutrophil potential at the clonal level 6, 10 . However, granulocytes also include functionally distinct mast cells, basophils and eosinophils, each specified through the action of critical transcription factors 13 , and the presence of such potential in GMPs has so far not been analyzed systematically. Therefore, whether the LMPP and CMP pathways generate the same complement of myeloid cell types has remained an open question.
Here we used global gene profiling of single pre-GMs to identify molecularly distinct pre-GM subsets defined by differential expression of Gata1 (which encodes the transcription factor GATA-1) and Flt3 (which encodes the receptor tyrosine kinase Flt3). Gata1 was of particular interest, as in addition to its critical role in megakaryocyte and erythrocyte development 14, 15 , GATA-1 is expressed in eosinophils, basophils and mast cells (but not monocytes-macrophages or neutrophils) and is important for their differentiation [16] [17] [18] . By generating reporter mice expressing enhanced green fluorescent protein (EGFP) from Gata1 (Gata1-EGFP), we were able to fractionate myeloid progenitors on the basis of their Gata1 expression and identify subpopulations with distinct myeloid lineage potential. Gata1-EGFP + (GE + ) pre-GMs and GE + GMPs gave rise to mast cells and eosinophils but lacked monocyte-macrophage potential and had little or no neutrophil potential. Conversely, Gata1-EGFP − (GE − ) pre-GMs and GE − GMPs (as well as LMPPs) generated monocytes and neutrophils but no mast cells and few eosinophils. Notably, monocyte-neutrophil potential and mast cell-eosinophil potential segregated before separation from other blood lineages, as GE + pre-GMs generated megakaryocytes and erythroid cells, whereas LMPPs contained robust B lineage and T lineage potential. Our findings therefore identify an early blood-lineage-fate 'decision' that segregates lymphoidmacrophage-neutrophil potential from mast cell-eosinophilmegakaryocytic-erythroid potential and thereby establishes separate myeloid-erythroid and myelo-lymphoid differentiation pathway and generates two distinct myeloid-restricted progenitor subsets, instead of a common GMP harboring all monocyte-macrophage potential and granulocyte potential.
RESULTS

Identification of pre-GM molecular heterogeneity
To address whether the same myeloid differentiation pathways emerge from CMPs and LMPPs, we performed global single-cell gene profiling of bone marrow pre-GMs 6 , the earliest progenitors predicted to be shared by the two pathways [6] [7] [8] . RNA sequencing of 63 single pre-GMs was followed by unsupervised clustering with the 100 genes with greatest variance across the entire cell population. This led to the identification of two distinct pre-GM clusters (Supplementary Fig. 1a ) and 55 genes showing differential expression by the clusters (P < 0.05; false-discovery rate < 0.05; Supplementary Fig. 1b) , as potential sub-population classifiers. Clustering with this gene set identified three distinct pre-GM subpopulations defined by expression of Gata1 but not Flt3, expression of neither Gata1 nor Flt3, and expression of Flt3 but not Gata1 (Fig. 1a) , a pattern that was validated by targeted singlecell gene-expression analysis (Fig. 1b) . This analysis also identified Gata1 as an optimal classifier that was homogeneously and selectively expressed in a distinct subpopulation of pre-GMs that did not express Flt3 but was not detected in pre-GMs that did express Flt3 (Fig. 1b) . Notably, Gata1 expression and Flt3 expression have been used to define CMPs 11 and LMPPs 12 , respectively, within the CD34 + Lin − Sca-1 + c-Kit + (LSK) population, which would suggest that expression of Gata1 and Flt3 might have the potential to identify pre-GM subsets derived from these distinct upstream progenitors.
Gata1 expression defines distinct myeloid progenitors
The Gata1-EGFP transgene used to define CMPs 11 lacks key regulatory elements [19] [20] [21] and is not expressed in GMPs 22 . We therefore generated a Gata1-EGFP reporter mouse line using a bacterial artificial chromosome transgenic construct containing all known Gata1 regulatory sequences, in which an expression cassette encoding EGFP replaced the coding part of the second exon of Gata1 (Supplementary Fig. 1c ). In these Gata1-EGFP reporter mice, distinct GE + and GE − subsets were present among pre-GMs and GMPs ( Fig. 1c and Supplementary Fig. 1d ). Within the bone marrow multi-potent LSK compartment, HSCs are CD150 + LSK cells 23 , whereas LMPPs are Flt3 hi LSK cells 12 . The CD150 + LSK cell population contained a substantial fraction of GE + cells ( Fig. 1d and Supplementary Fig. 1e ), but only GE − CD150 + LSK cells had HSC function in vivo (Supplementary Fig. 2a-d) . We therefore defined HSCs as CD150 + GE − LSK cells here. Similarly, a small fraction (2-3%) of LMPPs had low Gata1-EGFP expression (Fig. 1d) . Published studies have shown that approximately 2% of LMPPs possess detectable megakaryocyte potential 12 , and we found that this megakaryocyte potential was confined to the small GE + sub-fraction of Flt3 hi LSK cells (Supplementary Fig. 2e) , which supported the proposal of the existence of an LMPP population devoid of platelet-forming capacity 12, 24, 25 and led us to stringently define and sort LMPPs as Flt3 hi GE − LSK cells in this study. Notably, Gata1-EGFP expression mirrored endogenous Gata1 mRNA expression both at the population level (Fig. 1e) and in analysis of single pre-GMs (Supplementary Fig. 2f ). The Gata1-EGFP reporter, therefore, identified transcriptional heterogeneity within the phenotypic HSC, LMPP, pre-GM and GMP populations.
Early separation of macrophage and mast cell potential Quantitative PCR analysis of lineage-specific gene expression showed that genes affiliated with Mk-E cells (Itga2b, Klf1, Epor and Gata2) were expressed 'preferentially' in GE + pre-GMs and GMPs, the Mk-E progenitor (pre-Meg-E) population (Lin − Sca-1 − cKit + CD41 − FcγRII/III − CD150 + CD105 − ), the megakaryocyte progenitor (MkP) population (Lin − Sca-1 − c-Kit + CD150 + CD41 + ) and erythroid colony-forming unit progenitor (pre-CFU-E) population (Lin − Sca-1 − c-Kit + CD41 − FcγRII/III − CD150 + CD105 + ) (Fig. 1f) , as were mast cell-related genes (Cma1 and Mcpt1; Fig. 1g ), whereas macrophage-related genes (Cd68 and Emr1; Fig. 1h) , neutrophilrelated genes (Csf3r and Ctsg; Fig. 1i ) and lymphoid cell-related genes (Rag1 and Cmah; Fig. 1j ) were expressed selectively in LMPPs, GE − pre-GMs and GE − GMPs. The divergent expression of macrophage-neutrophil-related genes versus mast cell-related genes in GE + pre-GMs and GMPs versus GE − pre-GMs and GMPs suggested that these progenitors might generate different myeloid cell types. We therefore cultured GE + pre-GMs and GE − pre-GMs for 8 d under 'pan-myeloid' conditions (with the cytokines interleukin 3 (IL-3), IL-5, IL-9, stem-cell factor (SCF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)) and assessed the resulting cultures by cytospin morphology and gene-expression analysis. Morphological analysis showed that LMPPs and GE − pre-GMs generated monocytes but no mast cells, whereas GE + pre-GMs generated mast cells but no monocytes (Fig. 1k) . Polymorphonuclear (PMN) cells were present in both cultures, with neutrophil morphology (small cell size and a highly condensed and segmented nucleus) evident in those derived from GE − pre-GMs and LMPPs, whereas those derived from GE + pre-GMs were generally larger with less-condensed nuclei (Fig. 1k) . Consistent with the observed separation of mast cell potential and monocyte-macrophage potential, mast cell-specific genes were expressed exclusively in the cultures derived from GE + pre-GMs (Fig. 2a) , and monocyte-macrophage-specific genes were expressed selectively in those derived from LMPPs and GE − pre-GMs (Fig. 2b) . Finally, while the genes encoding the myeloid transcription factors PU.1 and C/EBPα were expressed in all cultures, expression of Gata1 and Gata2 was confined to cultures derived from GE + pre-GMs (Fig. 2c,d) .
To determine the frequency and distribution of granulocyte and monocyte-macrophage potential within the different progenitor populations at the single-cell level, we individually cultured sorted progenitor cells and analyzed their myeloid lineage output at several time points. While single LMPPs, GE − pre-GMs and GE − GMPs produced large numbers of monocytes, mast cell potential was never detectable in cultures of single LMPPs or GE − GMPs and was very rare (<2% of cultures) in GE − pre-GM single cell-derived cultures, at all time points investigated (Fig. 2e) . In contrast, monocytes were generated only very rarely (<2% of single cell cultures) from GE + pre-GMs or GE + GMPs, whereas mast cell potential was very abundant in GE + pre-GMs or GE + GMPs (Fig. 2e) . Combined monocyte and mast cell morphology was exceptionally rare, found in only 2 of over 1,000 single cell-derived clones of all progenitors analyzed (Fig. 2e) . Notably, this was not due to any inability of the culture system to support the development of these two cell types simultaneously, as culture of multi-potent HSCs or co-culture of GE + pre-GMs and GE − pre-GMs generated combined mast cells and monocytes with high frequency (Supplementary Fig. 2g,h ). Both monocytes and mast cells were observed in conjunction with other granulocytes with high frequency in single cell-derived clones from GE + pre-GMs (22-33%), GE − pre-GMs (~50%) and LMPPs (65%) and also in single cell-derived 
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Low ND Expression (log 2 mRNA) npg clones from GE + GMPs and GE − GMPs at a lower frequency (Fig. 2e) . The PMN cells associated with monocytes showed neutrophil morphology, whereas those associated with mast cells seemed larger, with less-condensed nuclei (Fig. 2f) . These results demonstrated the distinct lineage potential of GE + myeloid progenitors versus that of GE − myeloid progenitors.
Eosinophil potential of GE + pre-GMs and GE + GMPs
While the data presented above showed that mast cell potential and monocyte-macrophage potential were separated before the formation of pre-GMs and GMPs, the nature of the additional granulocytelineage potential associated with these progenitors remained unclear.
To address this issue, we performed microarray-based global gene profiling of pre-GMs, GMPs, HSCs, LMPPs, CLPs (Lin − B220 − Sca-1 lo c-Kit lo Flt3 + IL-7Rα + ) 26 and pre-Meg-E cells. Consistent with their similar granulocyte-monocyte lineage 'readouts' , LMPPs, GE − pre-GMs and GE − GMPs clustered together by principal-component analysis, in close association with CLPs, whereas GE + pre-GMs and GE + GMPs formed a separate cluster, associated with pre-Meg-E cells (Fig. 3a) . Direct comparison of the transcriptomes of GE + GMPs and GE − GMPs showed that GE + GMPs had higher expression of mast cell-and eosinophil-specific genes, whereas GE − GMPs had higher expression of numerous monocyte-macrophage-and neutrophilassociated genes (Supplementary Table 1 ). We therefore investigated the possibility that the PMN cells derived from GE + pre-GMs and GE + GMPs were eosinophils. First, we cultured GE + GMPs and GE − GMPs in the presence of SCF, GM-CSF and IL-5 ( Supplementary Fig. 3a) and assessed the morphology and gene expression of the resulting cultures. Under these conditions, GE + GMPs did not generate mast cells but generated only large PMN cells with uncondensed nuclear morphology, while GE − GMPs generated cells with monocyte and neutrophil morphology (Fig. 3b) . Gene-expression analysis indicated selective expression of eosinophil-specific genes (Il5ra, Ccr3, Siglec5 and Prg2) in GE + GMP cultures ( Fig. 3c) and of monocyte-macrophage-specific genes (Cd68, Lpl, Lrp1 and Mpeg1) in GE − GMP cultures (Fig. 3d) . In both cases, the cell-type specificity of gene expression was confirmed by analysis of macrophages and eosinophils sorted from the peritoneal cavity as controls. Cytospins indicated that the morphology of the eosinophil-like cells derived in vitro from GE + GMPs was similar to that of purified peritoneal eosinophils ( Supplementary Fig. 3b ). These results indicated the selective development of eosinophils from GE + GMPs. We also performed flow cytometry of the cells differentiated from GE + pre-GMs and GE − pre-GMs, as well as from GE + GMPs and GE − GMPs, following culture under 'pan-myeloid cytokine' conditions. Cells with a FcεRIα + c-Kit + GE + mast cell surface phenotype were abundant in GE + pre-GM and GE + GMP cultures, whereas Mac-1 + Ly6G lo GE − monocytes and Mac-1 + Ly6G hi GE − neutrophils were the principal cell types generated from GE − pre-GMs and GE − GMPs (Fig. 4a,b) ; this indicated that neutrophil potential was selectively associated with GE − pre-GMs and GE − GMPs. Eosinophil, neutrophil and mast cell identities were further confirmed by analysis of the expression of lineage-specific genes ( Supplementary  Fig. 3c-f) . FcεRIα − c-Kit − SiglecF + GE + eosinophils were inefficiently generated under the 'pan-myeloid' conditions (Fig. 4a,b) , probably because of overgrowth by mast cells. To circumvent this, we cultured Lpl mRNA (fold × 10 
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GMPs in the presence of SCF, GM-CSF and IL-5 and observed selective development of eosinophil-like cells in GE + GMP cultures, while GE − GMPs gave rise to monocytes and neutrophils but few or no eosinophils, even under conditions favoring eosinophil development (Fig. 4c) . Thus, on the basis of analyses of morphology, surface markers and gene expression, we concluded that GE + GMPs gave rise to eosinophils and mast cells but did not produce detectable neutrophils or monocytes. Finally, to accurately 'co-localize' lineage potential in single progenitor cells, we combined morphological analysis of cytospins of single cell-derived cultures with immunocytochemistry directed against EGFP to distinguish GE + eosinophils from GE − neutrophils (Fig.  4d) . GE + pre-GM and GE + GMP populations included a large proportion of bi-potent mast cell-eosinophil progenitors, whereas GE − LMPP, GE − pre-GM and GE − GMP populations included an abundance of bi-potent neutrophil-monocyte progenitors (Fig. 4e) . In addition, under 'pan-myeloid' conditions, we observed the emergence of FcγRII/III + GE + cells from GE + pre-GMs and FcγRII/III + GE − cells from GE − pre-GMs and LMPPs that in both cases displayed the clonogenic lineage potential of the corresponding GE + or GE − GMP population (Supplementary Fig. 4a,b) , in further support of the proposal of the existence of independent and functionally distinct GE + and GE − progenitor hierarchies. Comparison of the gene-expression profiles of GE + GMPs and GE − GMPs identified genes encoding cell-surface markers that were 'preferentially' expressed by the GE + subset (such as Cd55 and Il1rl1) or the GE − subset (such as Ly6c) (Supplementary Table 1) . While cell-surface expression of the cytokine receptor ST2 (encoded by Il1rl1) was not detectable on pre-GMs or GMPs with the antibodies available, the convertase inhibitor CD55 (encoded by Cd55) and surface marker Ly6C (encoded by Ly6c) were expressed selectively on GE + pre-GMs and GMPs and on GE − pre-GMs and GMPs, respectively (Supplementary Fig. 4c ). In agreement with such selective expression, the expression of these markers allowed the separation of progenitors with a restricted monocyteneutrophil potential (Ly6C + pre-GMs and GMPs) or restricted mast cell-eosinophil potential (CD55 + pre-GMs and GMPs), without the use of the Gata1-EGFP transgene (Supplementary Fig. 4d ). Overall, these results indicated that mast cell-eosinophil potential was present in GE + pre-GMs and GE + GMPs, whereas monocyte-neutrophil potential was present in LMPPs, GE − pre-GMs and GE − GMPs.
Definition of two progenitor domains by Gata1 expression
We further investigated the extent to which the progenitors identified had other lineage potential. Comparison of 'lineage programming' in GE − pre-GMs and GE + pre-GMs by gene-set-enrichment analysis 27 showed considerable enrichment for the expression of Mk-Eassociated genes in GE + pre-GMs and of lymphoid cell-related genes in GE − pre-GMs (Fig. 5a) . All the pre-GM and GMP populations identified generated colonies when cultured under myeloid conditions (Fig. 5b) . In contrast, megakaryocytic or erythroid colony-forming ability was associated mainly with GE + pre-GM populations, which showed an Mk-E potential similar to that seen for pre-Meg-E cells (Fig. 5c,d ) and included multi-potent cells with combined npg granulocyte and Mk-E potential but no monocyte-macrophage potential (Fig. 5e,f) . Conversely, B lymphoid and T lymphoid potential was high in LMPPs but was also substantial in GE − pre-GMs but not GE + pre-GMs ( Fig. 5g and Supplementary Fig. 4e ).
Antagonistic transcription factor pairs, including PU.1-GATA-1 and C/EBP-FOG-1, have been proposed to be co-expressed in multi-or bi-potent progenitors, and resolution of the antagonism has been proposed to underlie lineage bifurcations 28 . We therefore 
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A r t i c l e s measured the expression of those and other key transcription factors in GE + pre-GMs and GMPs, as well as in GE − pre-GMs and GMPs, and in HSCs, LMPPs, pre-CFU-E cells, pre-Meg-E cells and CLPs, to determine if their expression was consistent with the associated lineage potential of each population (Fig. 6) . Most notably, Cebpa (which encodes C/EBPα), Cebpb (which encodes C/EBPβ) and Zfpm1 (which encodes FOG-1) were all expressed in GE + pre-GMs, with Zfpm1 being downregulated and Cebpa and Cebpb being upregulated in GE + GMPs. The converse change, upregulation of Zfpm1 and downregulation of Cebpa and Cebpb, was seen in pre-Meg-E cells. The FOG-1 target gene Trib2 (ref. 29) , which encodes a product (TRB2) that mediates the degradation of C/EBPα and C/EBPβ 30, 31 , was upregulated in pre-Meg-E cells, consistent with the proposed role of C/EBP-FOG-1 antagonism in resolving the multi-potency of GE + pre-GMs 29 and with the observed ability of FOG-1 to suppress differentiation of the eosinophil and mast cell lineages 32, 33 . Sfpi1 (which encodes PU.1) and Gata1 were expressed in GE + pre-GMs, with Sfpi1 being downregulated in Mk-E-committed pre-Meg-E cells. Gata1 and Sfpi1 were co-expressed in GE + GMPs, which indicated that downregulation of Gata1 was not decisive for the commitment of GE + pre-GMs to granulocyte lineages and consistent with PU.1's being required for mast cell differentiation 34 . Finally, genes encoding key transcriptional regulators of the differentiation of monocytes-macrophages (Irf8 and Klf4) 35 and neutrophils (Gfi1) 36 had higher expression in LMPP and GE − pre-GM and GMP populations than in GE + pre-GMs and GMPs. These data identified LMPPs and GE + pre-GMs as distinct multi-potent progenitors with non-overlapping lineage potential, with the former producing lymphocytes, neutrophils and monocytesmacrophages and the latter producing erythrocytes, platelets, eosinophils and mast cells.
Functional heterogeneity of GE − pre-GMs Lymphoid-lineage potential has been associated with Flt3 + pre-GMs 37 . By flow cytometry we observed that Flt3 + pre-GMs were exclusively GE − (Fig. 7a) . The selective presence of lymphoid potential in Flt3 + GE − pre-GMs but not Flt3 − GE − pre-GMs raised the possibility that these two populations also differed in other lineage potential.
Analysis of bulk and single-cell cultures showed that both Flt3 + GE − pre-GMs and Flt3 − GE − pre-GMs generated monocytes and neutrophils (Fig. 7b,c) , with the Flt3 − GE − pre-GMs being perhaps more biased toward neutrophil production. While mast cells did not develop from either progenitor population, a small number of eosinophils developed in the bulk Flt3 − GE − pre-GM cultures (Fig. 7b) , and 7% of clones derived from single Flt3 − GE − pre-GMs showed combined neutrophil and eosinophil morphology (Fig. 7c) . These results indicated that a minor but distinct fraction of Flt3 − GE − pre-GMs was restricted to neutrophil and eosinophil differentiation. Quantitative RT-PCR profiling of single pre-GMs confirmed the expression of Gata1 in GE + pre-GMs and of Flt3 in Flt3 + GE − pre-GMs, with Sfpi1 mRNA Gata1 mRNA (fold) Gata2 mRNA (fold) npg expression being similar across the three pre-GM subsets (Flt3 + GE − , Flt3 − GE − and GE + ) (Fig. 7d-f) , consistent with their myeloid-progenitor identity. Mk-E lineage-specific genes and mast cell lineage-specific genes were co-expressed in >90% of single GE + pre-GMs, and genes encoding antagonistic transcription factor pairs, such as Sfpi1-Gata1 and Cebpa-Zfpm1, were co-expressed with high frequency (32 of 48 cells and 17 of 48 cells, respectively) in single GE + pre-GMs (Fig. 7g) , suggestive of the molecular properties of multi-potent progenitors. Co-expression of Sfpi1-Gata1 and Cebpa-Zfpm1 was not observed in Flt3 + or Flt3 − GE − pre-GMs, which instead had high expression of monocyte-macrophage-and neutrophil-related genes such as Irf8 and Csf3r (Fig. 7g) , consistent with the presence of such lineage potential in both GE − pre-GM sub-populations. In addition, the proportion of Flt3 + pre-GMs was lower in mice deficient in the Flt3 ligand than in their wild-type counterparts ( Supplementary Fig. 5a,b) , which suggested that Flt3 signaling regulated the Flt3 + pre-GM subset. In contrast, GE + pre-GMs and GE + GMPs were maintained in mice with conditional deletion of a loxP-flanked Gata1 allele by Cre recombinase expressed under control of the interferon-inducible gene Mx1, after induction by the synthetic RNA duplex poly(I:C) ( Supplementary  Fig. 5c,d ). Consistent with published findings 38 , Gata1-null GE + progenitors differentiated into mast cells in vitro ( Supplementary  Fig. 5e,f) , possibly due to redundancy with Gata2 in these progenitors. The gene expression of the myeloid progenitors identified was therefore consistent with the lineage potential observed.
In in both the spleen and bone marrow of the reconstituted mice ( Fig. 8a and Supplementary Fig. 6b,c) . However, overall engraftment levels, in particular of eosinophils, were low, and no Lin − Ly6G − cKit + FcεR1α + mast cells were detected ( Fig. 8a and Supplementary  Fig. 6b,c) . To overcome that obstacle, we assessed the ability of GMPs and pre-GMs to engraft after intraperitoneal injection and found that total engraftment of the peritoneum by both pre-GMs and GMPs was one to two orders of magnitude greater than that in bone marrow and spleen after intrafemoral transplantation ( Supplementary  Fig. 6d ), and mast cell development was also readily detected (Fig. 8b) . Following intraperitoneal transplantation, GE + GMPs generated exclusively peritoneal mast cells and eosinophils, whereas only monocytes and neutrophils were derived from GE − GMPs (Fig. 8c) . Similarly, GE + pre-GMs produced predominantly mast cells and eosinophils, whereas Flt3 + GE − pre-GMs and LMPPs generated almost exclusively neutrophils and monocytes (Fig. 8d,e) . The cellular phenotypes defined by flow cytometry were further confirmed by morphology (Supplementary Fig. 6e-h ) and selective GE expression in eosinophils and mast cells ( Supplementary  Fig. 6i ). GE + pre-GMs generated low numbers of neutrophils (but no monocytes), and LMPPs and Flt3 + GE − pre-GMs generated limited numbers of eosinophils (but no mast cells) (Fig. 8d-e) , which indicated that the more upstream myeloid progenitors (LMPPs and npg A r t i c l e s pre-GMs) retained some lineage plasticity restricted to the eosinophil and neutrophil lineages in vivo, which was lost in both GE + GMPs and GE − GMPs (Fig. 8c-e) . These results confirmed the same lineage potential in vivo as that noted in vitro for both GE + myeloid progenitors (GE + pre-GMs and GE + GMPs) and GE − progenitors (LMPPs, GE − pre-GMs and GE − GMPs). We therefore propose to designate GE + pre-GMs as candidate erythroid-megakaryocyteprimed multi-potent progenitors (EMkMPPs) and GE + GMPs as eosinophil-mast cell progenitors (EoMPs). In contrast, since GE − pre-GMs and GE − GMPs generated predominantly neutrophils and monocytes, we propose to designate them as pre-neutrophilmonocytes progenitors (pre-NMs) and neutrophil-monocyte progenitors (NMPs), respectively. In various current hematopoietic models, all monocyte-macrophage lineage potential and granulocyte lineage potential is proposed to reside in one common GMP 2, [8] [9] [10] 12, 39, 40 (Supplementary Fig. 7a,b) . Instead, our findings have indicated the organization of GE + progenitors (EMkMPPs and EoMPs) and GE − progenitors (LMPPs, pre-NMs and NMPs) into largely separate hierarchies that generate lymphoid cells, neutrophils and monocytes-macrophages, eosinophils, mast cells, platelets and erythroid cells, and respectively (Supplementary Fig. 7c,d ).
DISCUSSION
Here we have prospectively isolated and characterized distinct, myeloid progenitor populations restricted to either the neutrophilmonocyte fate (pre-NM and NMP) or eosinophil-mast cell fate (EoMP). We have also prospectively isolated and characterized candidate multi-potent progenitor cells with combined Mk-E potential and eosinophil-mast cell potential (EMkMPPs). In addition, we found that LMPPs produced neutrophils and monocytes but no mast cells and few or no eosinophils.
While existing models indicate that the segregation of monocytemacrophage potential and granulocyte potential occurs downstream of a common GMP, our results suggested that the separation of lineages that expressed Gata1 (megakaryocytes, erythrocytes, eosinophils and mast cells) and lineages that did not express Gata1 (lymphocytes, neutrophils and monocytes) represented an early lineage bifurcation of the multi-potent HSCs. These findings substantially change the view of how myeloid cell types are specified by suggesting that mast cells and eosinophils are generated from an EMkMPP shared with platelets and erythrocytes, rather than from a common GMP. This type of lineage relationship has been suggested before on the basis of observations of myeloid malignancies 41 . Platelets have important innate immunological functions, acting as sentinels and providing chemotaxis of myeloid effector cells 42 , and the platelet-ancestral thrombocyte is capable of bacterial phagocytosis 43 . These are all functions shared with mast cells 44 , consistent with the evolution of mast cells and platelets through specialization from a common ancestral cell with both hemostatic function and phagocytic function. Our results suggest that eosinophils might have evolved from the same GATA-1-expressing hematopoietic branch, possibly as an adaptation to parasites. In contrast, we found that monocytes-macrophages were developmentally closely related to lymphoid cells, as has already been suggested by the identification of progenitors restricted to macrophage and lymphoid differentiation in both fetal hematopoiesis [45] [46] [47] and adult hematopoiesis 48 .
Published lineage analysis of myeloid colonies derived from heterogeneous human CD34 + hematopoietic cells is compatible with a similar separation of human GATA-1-expressing granulocyte lineages along with megakaryocytic lineage potential and erythroid lineage potential, with the important distinction that considerable macrophage potential was also observed together with the GATA-1-expressing lineages 49 . This might be related to the fact that the human cell populations investigated typically also had extensive lymphoid potential of unknown relationship to the granulocyte lineages investigated. 
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CMPs have been defined as having myeloid-lineage potential and Mk-E-lineage potential but lacking lymphoid-lineage potential 11, 50 and would potentially generate both pre-NM-NMP populations and MkEMPP-EoMP populations. However, it has not been established if the CMP population as currently defined (Lin − Sca-1 + c-Kit + CD34 + CD41 hi ) 50 includes cells with monocyte-macrophage potential as well as all granulocyte potential at the clonal level, and further studies will therefore be needed to firmly establish its relationship to the myeloid progenitor populations identified here. In addition, our studies do not preclude the possibility that an upstream progenitor with the same lineage potential as the EMkMPP exists, for example, within the proposed CMP compartment.
In summary, our findings have provided an improved cellular and molecular template for elucidation of the evolutionary and developmental relationships of hematopoietic cell types, as well as the identification of cells-of-origin of hematopoietic malignancies. Our results emphasize the power of single-cell transcriptome analysis to simultaneously resolve cellular heterogeneity and identify the molecular determinants selectively and uniformly expressed in novel cell subsets to allow their purification and functional characterization.
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Methods and any associated references are available in the online version of the paper.
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